Curated GI articles February 18th, 2022: FDA approves prep-free CRC screening test

Curated GI articles February 18th, 2022:
FDA approves prep-free CRC screening test2

AI will change healthcare ‘in ways we have not imagined,’ gastroenterologist says (Becker’s GI & Endoscopy)
Vivek Kaul, MD, a GI at the University of Rochester (N.Y.) Medical Center, discusses the forces deciding the future of healthcare and how ASCs can thrive.

Kallyope Raises $236M Series D Financing to Fuel Expansion of Novel Gut-Brain Axis Therapeutic Programs (Kallyope)
The funds will be used to advance drug discovery, clinical trials, and the pipeline of multiple programs across a broad range of therapeutic areas.

Health Care Private Equity Trends to Watch in 2022 (JD Supra)
Private equity interest in the health care sector is at an all-time high, spurred by the digital health revolution, value-based care.

Gastroenterology consolidation shows no signs of slowing (Becker’s GI & Endoscopy)
The GI sector continued to experience rapid consolidation in the fourth quarter in 2021, according to a market update from Provident.

4 ways GI ASCs can thrive in a competitive market (Becker’s GI & Endoscopy)
Three gastroenterology leaders joined Becker’s to discuss tips for ASCs to thrive in competitive markets.

FDA approves IDE application for novel polyp detection test (Healio)
The FDA has granted investigational device exemption to medical diagnostics company Check-Cap to evaluate C-Scan, a new screening test that detects precancerous polyps.

Detecting & Treating Arthralgia in IBD: What the Gastroenterologist Needs to Know (Reach MD)
The podcast discusses screening tools gastroenterologists can use to differentiate the types of arthralgia in their patients as well as key management approaches.

Mobile CBI App Beneficial for Anxiety and Depression in Patients With Functional GI disorders  (Psychiatry Advisor)
Use of digital cognitive-behavioral intervention was associated with statistically and clinically significant improvement in anxiety and depression.

Robotic ‘mini-tank’ to enhance colonoscopy techniques (Healthcare in Europe)
A miniature colonoscopy robot developed to collect images and biopsies could have clear benefits for both patients and endoscopists.

An extremely dangerous case of acute massive upper gastrointestinal bleeding: a case report (BMC Gastroenterology)
The report highlights an adult case of a mediastinal abscess corroding the LSA, resulting in delayed but high-risk massive upper GI bleeding.

AGA clinical practice update: Managing refractory gastroparesis (MDedge)
A new clinical practice update aims to help physicians treat medically refractory gastroparesis with practical advice stemming from expert opinion and a literature review.

Combination therapy strategies: Unlocking the next wave of innovation in IBD (Linkedin)
David M. Lee, M.D., Ph.D. — Global Immunology Therapeutic Area Head at Janssen Pharmaceutical Companies discusses the potential for combination therapy to unlock refractory disease.

Motus GI Receives FDA Clearance to Market the Pure-Vu® EVS System (Globe Newswire)
The new Pure-Vu EVS System is intended to improve speed of set-up, enhance navigation capabilities in tortuous anatomy.

Cold-Snare Polypectomy Safe if DOACs Withheld on Day of Procedure (Medscape)
Colorectal cold-snare polypectomy is safe to perform if direct-acting oral anticoagulants are withheld on only the day of the procedure, a study suggests.

Walmart May Soon Become The Largest Primary Care Provider In The Country (Forbes)
With an incredible arsenal of resources, a clear vision for the road ahead, and a visionary leadership team, Walmart will only continue to grow in this space.

Investigational Microbial Treatment Reduces Recurring CDI (Gastroenterology & Endoscopy News)
An investigational oral microbiome treatment was 70% more effective than placebo in preventing Clostridioides difficile infection recurrence.

Microbiome status unrelated to current celiac disease activity, severity (Healio)
Pre-existing fecal microbiome diversity was unaffected by gluten challenge in patients with celiac disease and nonceliac gluten sensitivity.

Cells in Fecal Wash a More Powerful Biomarker Than Biopsy for IBD Inflammation (Medscape)
A fecal wash sample yields more information and may help inform diagnosis, disease monitoring, and treatment selection.

More Hot headlines in GI

Athenahealth Acquired by Hellman & Friedman and Bain Capital (Business Wire)

EvoEndo Announces US FDA 510(k) Clearance for Single-Use Unsedated Transnasal Endoscopy (TNE) System (Business Wire)

Salix Announces 2022 Gastrointestinal Health Scholars Program (PR Newswire)

Healthcare Industry Still Lacks Inclusivity And Accessibility (Forbes)

Q&A: Will Congress act to extend, expand telehealth coverage beyond COVID-19? (Healio)

Gut Microbiota for Health World Summit 2022 (MDedge)

Study looks at ties between long COVID, GI symptoms (The Freelance Star)

Progressive Early Dysregulation of Gut Microbiota Associated With Autism Spectrum Disorder (Gastroenterology Advisor)

Solutions for Expanding the GI Pipeline for Underrepresented Populations (AGA)

Three-drug combination active in metastatic colorectal cancer subset (Healio)

Microorganisms in the gut are linked to cognitive function (Medical News Today)

Videos: Interviews with GI Leaders  (NextServices)

_

COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.